Next Article in Journal
Evaluation of the Quality of Services in Primary Health Care Institutions
Previous Article in Journal
The Effect of β-Carotene Against Adriamycin Toxicity on the Embryo Formation
 
 
Medicina is published by MDPI from Volume 54 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Survival of Patients With Testicular Cancer in Lithuania During 1999–2002

by
Agnius Juška
1,
Albertas Ulys
2,
Laura Kairevičė
3,
Giedrė Smailytė
4,
Edgaras Stankevičius
5,
Rasa Jančiauskienė
3 and
Mindaugas Jievaltas
6,*
1
Faculty of Medicine, Vilnius University
2
Oncosurgery Center, Institute of Oncology, Vilnius University
3
Department of Oncology, Medical Academy, Lithuanian University of Health Sciences
4
Cancer Control and Prevention Center, Institute of Oncology, Vilnius University
5
Department of Physiology, Medical Academy, Lithuanian University of Health Sciences
6
Department of Urology, Medical Academy, Lithuanian University of Health Sciences, Lithuania
*
Author to whom correspondence should be addressed.
Medicina 2011, 47(1), 8; https://doi.org/10.3390/medicina47010008
Submission received: 23 February 2010 / Accepted: 6 January 2011 / Published: 11 January 2011

Abstract

The aim of this study was to evaluate the survival of patients with testicular cancer in Lithuania during 1998–2002 and factors that influenced the survival.
Material and methods.
The survival rates of testicular cancer patients were evaluated using the data of the Lithuanian Cancer Registry for 1998–2002. The survival was evaluated using the Kaplan-Meier method and log-rank test in order to compare the survival rates. The observed survival rates were calculated.
Results. The 5-year observed survival rate in Lithuania was 71.2% (95% CI, 64.4%–77.5%). The survival of testicular cancer patients depended on age at the time of diagnosis, histology of tumor, stage and extent of disease.
Conclusions.
The survival of patients with testicular cancer in Lithuania was substantially lower than in other European countries. The better survival was associated with younger age and lesser extent of metastases.
Keywords: testicular cancer; survival; Kaplan-Meier method; log-rank test testicular cancer; survival; Kaplan-Meier method; log-rank test

Share and Cite

MDPI and ACS Style

Juška, A.; Ulys, A.; Kairevičė, L.; Smailytė, G.; Stankevičius, E.; Jančiauskienė, R.; Jievaltas, M. Survival of Patients With Testicular Cancer in Lithuania During 1999–2002. Medicina 2011, 47, 8. https://doi.org/10.3390/medicina47010008

AMA Style

Juška A, Ulys A, Kairevičė L, Smailytė G, Stankevičius E, Jančiauskienė R, Jievaltas M. Survival of Patients With Testicular Cancer in Lithuania During 1999–2002. Medicina. 2011; 47(1):8. https://doi.org/10.3390/medicina47010008

Chicago/Turabian Style

Juška, Agnius, Albertas Ulys, Laura Kairevičė, Giedrė Smailytė, Edgaras Stankevičius, Rasa Jančiauskienė, and Mindaugas Jievaltas. 2011. "Survival of Patients With Testicular Cancer in Lithuania During 1999–2002" Medicina 47, no. 1: 8. https://doi.org/10.3390/medicina47010008

Article Metrics

Back to TopTop